Ketamine Reverses Amblyopia – Lazy Eye – By Restoring Brain Plasticity

MedicalResearch.com Interview with:

Steven Grieco, PhD Postdoctoral Scholar Xu Lab, UCI

Dr. Grieco

Steven Grieco, PhD
Postdoctoral Scholar
Xu Lab, UCI

MedicalResearch.com: What is the background for this study?

Response: In recent years the drug ketamine, which has been used safely as a dissociative anaesthetic for decades, has gained widespread interest in the field of psychiatry for its use as an antidepressant at low doses. In 2019 the FDA finally approved a nasal spray that delivers ketamine to patients with untreatable clinical depression.  Now, such patients go to the appropriate clinical setting and receive ketamine treatments, though this is not required daily for an effective outcome. In fact, studies have found that a single low dose ketamine treatment can result in beneficial improvements in mood that last for several days or even weeks. This suggests that ketamine treatment induces significant neural plasticity in the brain.

Since the mechanisms governing this ketamine-mediated neural plasticity were not known, our group studied this using the visual cortex as a model tissue. The visual cortex has perhaps the most well-characterized patterns of neural plasticity in the brain to date, and is an excellent arena in which to test hypotheses about the mechanisms of neural plasticity. In fact, the classical antidepressant fluoxetine (Prozac), which induces neural plasticity only after long-term chronic treatment, has been studied extensivley in the visual cortex as well.

MedicalResearch.com: What should readers take away from your report? 

Response: Our group, the Xiangmin Xu laboratory, at the University of California, Irvine (UCI) has uncovered the mechanism of action by which a single low dose of ketamine induces neural plasticity in the brain, or at least in the visual cortex. The visual cortex has a “critical period” during development, which is a window of time in which neural circuits are highly plastic.  If one eye has poor inputs during this critical period, the brain will ultimately ignore that eye, resulting in permanent non-reversible vision loss, a condition known as amblyopia or “lazy eye”. To our amazement, experimental animals which were made to have a  lazy eye, recovered vision in that eye even as adults if given a ketamine treatment. This unequivocally proves the potential of ketamine to induce significant levels of neural plasticity.

We then determined the mechanism by which ketamine is able to do this. We had a hunch that the most common inhibitory neuron in the brain, the parvabumin interneuron, might be involved, as other researchers had already discovered that ketamine disinhibits the brain. Therefore, we tested this hypothesis and discovered that ketamine treatment did reduce parvalbumin interneuron activity, resulting in disinhibition of the visual cortex, an effect considered to be a precursor to neural plasticity.

Then, after having combed through the existing literature some more, we discovered that ketamine had been shown to modulate the expression of a gene called neuregulin1 (NRG1), which regulates parvalbumin interneuron activity! We synthesized all of these findings and tested if ketamine-mediated neural plasticity depended on NRG1 signaling at parvalbumin interneurons, which was indeed the case. We then excitedly sent off our results to the prestigious journal Current Biology. 

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: Our laboratory group always keeps the potential of our research to benefit real people as our guiding principle. Therefore, we are highly motivated to apply our findings towards the understanding and treatment of post-traumatic stress disorder (PTSD). 

MedicalResearch.com: Is there anything else you would like to add? 

Response: We have no disclosures, but would like to thank the National Eye Institute (NEI) and the National Institute of Mental Health (NIMH) for their support.

Citation:

Grieco SF, Qiao X, Zheng X, Liu Y, Chen L, Zhang H, Yu Z, Gavornik JP, Lai C, Gandhi SP, Holmes TC, Xu X. Subanesthetic Ketamine Reactivates Adult Cortical Plasticity to Restore Vision from Amblyopia. Curr Biol. 2020 Sep 21;30(18):3591-3603.e8. doi: 10.1016/j.cub.2020.07.008. Epub 2020 Aug 20. PMID: 32822611.

JOIN OUR EMAIL LIST

We respect your privacy and will never share your details.

Last Modified: Oct 23, 2020 @ 10:38 pm

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.